Try our beta test site
91 studies found for:    Open Studies | "Mesothelioma"
Show Display Options
Rank Status Study
21 Not yet recruiting Adjuvant Pembrolizumab After Radiation Therapy for Lung-Intact Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Interventions: Radiation: Hemithoracic Radiation Therapy;   Radiation: Palliative Radiation Therapy;   Drug: Pembrolizumab
22 Recruiting Tumor-Infiltrating Lymphocytes and Low-Dose Interleukin-2 Therapy Following Cyclophosphamide and Fludarabine in Patients With Pleural Mesothelioma
Condition: Pleural Mesothelioma
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: Autologous tumor infiltrating lymphocytes (TILs);   Biological: Interleukin-2
23 Recruiting A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1)
Conditions: Pleural Mesothelioma;   Peritoneal Mesothelioma
Intervention: Drug: tremelimumab plus MEDI4736
24 Recruiting Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma
Conditions: Malignant Pleural Mesothelioma;   Mesothelioma
Interventions: Drug: Cisplatin;   Drug: Methotrexate;   Drug: Gemcitabine;   Other: Lung Cancer Symptom Scale for Mesothelioma Questionnaire
25 Recruiting Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR)
Condition: Malignant Pleural Mesothelioma
Interventions: Device: NovoTTF-100L device;   Drug: Pemetrexed;   Drug: Cisplatin or Carboplatin
26 Recruiting Study of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for Malignant Pleural Mesotheliomas
Condition: Mesothelioma
Interventions: Drug: Pemetrexed;   Drug: Cisplatin
27 Recruiting Autologous Dendritic Cell Vaccination in Mesothelioma
Condition: Malignant Pleural Mesothelioma
Intervention: Biological: dendritic cell vaccination plus chemotherapy
28 Recruiting Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma
Condition: Advanced Malignant Pleural Mesothelioma
Interventions: Drug: NGR-hTNF;   Drug: Placebo;   Other: Best Supportive Care
29 Not yet recruiting Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma
Condition: Malignant Pleural Mesothelioma
Interventions: Drug: Nintedanib;   Drug: Placebo
30 Recruiting Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Intervention: Drug: nivolumab and ipilimumab
31 Recruiting Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Intervention: Drug: intracavitary cisplatin-fibrin
32 Recruiting Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Pleural Epithelioid Mesothelioma;   Pleural Malignant Mesothelioma
Interventions: Radiation: Hypofractionated Radiation Therapy;   Radiation: Intensity-Modulated Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Procedure: Therapeutic Conventional Surgery
33 Recruiting Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Intervention: Genetic: Adoptive Transfer of re-directed T cells
34 Recruiting Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent
Conditions: Recurrent Pleural Malignant Mesothelioma;   Stage IV Pleural Mesothelioma
Intervention: Drug: Nintedanib
35 Recruiting Ph 2/3 Study in Subjects With MPM w/Low ASS 1 Expression to Assess ADI-PEG 20 With Pemetrexed and Cisplatin
Condition: Mesothelioma
Interventions: Drug: ADI-PEG 20 plus Pem Cis;   Other: Placebo plus Pem Cis
36 Not yet recruiting PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma
Condition: Pleural Mesothelioma Malignant Advanced
Interventions: Drug: Pembrolizumab;   Drug: Gemcitabine;   Drug: Vinorelbine
37 Recruiting Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma
Conditions: Mesothelioma;   BAP1 Loss of Function
Intervention: Drug: Tazemetostat
38 Recruiting Screening of Alberta Asbestos Exposed Workers for Lung Cancer and Mesothelioma
Conditions: Lung Cancer;   Mesothelioma
Interventions: Procedure: Low-dose computed tomography Annual scan x3;   Procedure: Low-dose computed tomography Baseline scan only
39 Recruiting Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers
Conditions: Lung Cancer;   Mesothelioma
Intervention:
40 Not yet recruiting Trial of Adcetris in CD30+ Malignant Mesothelioma
Conditions: Lung Diseases Due to External Agents;   Mesothelioma
Intervention: Drug: Brentuximab Vedotin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.